Interestingly, Liu et al. reported a correlation between nuclear architecture impairment and PD etiology by studying a genetic isogenic PD model containing the LRRK2 G2019S mutation treated with an HDAdV-mediated gene correction system. The gene discussed is LRRK2; the disease is Parkinson disease.